ISPE was present at the recent Brazil Affiliate Conference, held 24–26 October 2016 in São Paulo.
The conference was attended by ISPE CEO and President John Bournas, who spoke on the worldwide status of the biopharmaceutical market and provided an overview of organizational developments. This visit—the first by an ISPE CEO in over 15 years—reaffirmed ISPE’s commitment to sharing knowledge on a global basis with all of our Affiliates. In addition, Dr. Theodora Kourti, ISPE’s Senior Vice President of Global Regulatory Affairs, discussed ongoing regulatory initiatives that the organization is developing to benefit its international Members.
Also in attendance were representatives from Anvisa, the Brazilian National Health Surveillance Agency, and Sindusfarma, the industry syndicate of pharmaceutical products in the state of São Paulo.
Meeting highlights included the official passing of the gavel from outgoing President Alfonso Izarra to current President Marcelo Decanio, inauguration of a new Board, and recognition of the Affiliate’s companies of the year: Nordika Pharmaceutical Engineering and Libbs Farmacêutica.
“Over the past 20 years, there have been an increasing number of highly potent materials handled within the pharma industry, to the point where most modern products require some degree of containment or other exposure control to maintain safety,” said guide team member Peter Marshall, AstraZeneca (retired).
The event, organized by and for recent graduates and students by the ISPE Emerging Leaders Community of Practice (CoP), offered high-quality presentations and interactive workshops where participants...
As Head of Merck’s Global Manufacturing Operations and one of the most senior operations leaders in Merck, Sanat is responsible for Merck’s worldwide manufacturing operations and product supply, supporting global sales revenue of over $55 billion.
